Health behavior change: Can genomics improve behavioral adherence?

American Journal of Public Health

Volumn 102, Issue 3, 2012, Pages 401-405

  McBride, Colleen M ^a   Bryan, Angela D ^b   Bray, Molly S ^c   Swan, Gary E ^d   Green, Eric D ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; GENOMICS; HEALTH BEHAVIOR; HUMAN; PATIENT COMPLIANCE; PERSONALIZED MEDICINE; POLICY; RESEARCH;

BEHAVIOR THERAPY; GENOMICS; HEALTH BEHAVIOR; HUMANS; INDIVIDUALIZED MEDICINE; PATIENT COMPLIANCE; PUBLIC POLICY; RESEARCH;

EID: 84857305365     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300513     Document Type: Review

References (46)

1. Green ED. Guyer MS, National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011; 470(7333):204-213.
2. 3FOUR50 Connect-Collaborate-Create. Available at: http://www.3four50. com. Accessed December 19, 2011.
3. Mabry PL, Olster DH, Morgan GD, Abrams DB. Interdisciplinarity and systems science to improve population health: a view from the NIH Office of Behavioral and Social Sciences Research. Am J Prev Med. 2008;35(2 Suppl):S211-S224. (Pubitemid 351932081)
4. Brezis M, Wiist WH. Vulnerability of health to market forces. Med Care. 2011; 49(3):232-239.
5. Wellman RJ, Sugarman DB, DiFranza JR, Winickoff JP. The extent to which tobacco marketing and tobacco use in films contribute to children's use of tobacco: a meta-analysis. Arch Pediatr Adolesc Med. 2006;160(12):1285-1296. (Pubitemid 44901692)
6. Cohen EL, Caburnay CA, Rodgers S. Alcohol and tobacco advertising in Black and general audience newspapers: targeting with message cues? J Health Commun. 2011;16(6):566-582.
7. Harris JL, Pomeranz JL, Lobstein T, Brownell KD. A crisis in the marketplace: how food marketing contributes to childhood obesity and what can be done. Annu Rev Public Health. 2009;30:211-225.
8. Frosch DL, Grande D, Tarn DM, Kravitz RL. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health. 2010;100(1):24-32.
9. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52(40): 953-956.
10. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature. 2010;465(7299): 721-727.
11. Giles J. Social science lines up its biggest challenges. Nature. 2011;470 (7332):18-19.
12. King DE,Mainous AG 3rd, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med. 2009;122(6):528-534.
13. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16(2):CD000011.
14. O'Neill SC, McBride CM, Alford SH, Kaphingst KA. Preferences for genetic and behavioral health information: the impact of risk factors and disease attributions. Ann Behav Med. 2010;40 (2):127-137.
15. Robinson T, Mayer J, Weaver F. Prevention message fatigue as an influence on condom use among urban MSM [abstract]. Paper presented at: 131st Annual Meeting of the American Public Health Association, November 17, 2003. Available at: http://apha.confex.com/apha/131am/techprogram/paper57839.htm. Accessed December 12, 2009.
16. Goldberg JP. Nutrition and health communication: the message and the media over half a century. Nutr Rev. 1992;50(3):71-77.
17. Michie S, Jochelson K, Markham WA, Bridle C. Low-income groups and behavior change interventions: a review of intervention content, effectiveness and theoretical frameworks. J Epidemiol Community Health. 2009;63(8):610-622.
18. Johnson BT, Scott-Sheldon LA, Carey MP. Meta-synthesis of health behavior change meta-analyses. Am J Public Health. 2010;100(11):2193-2198.
19. Krebs P, Prochaska JO, Rossi JS. A meta-analysis of computer-tailored interventions for health behavior change. Prev Med. 2010;51(3-4):214-221.
20. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: Public Health Service; 2008.
21. Kaufman A, Augustson E, Davis K, Finney Rutten LJ. Awareness and use of tobacco quitlines: evidence from the Health Information National Trends Survey. J Health Commun. 2010;15(Suppl 3): 264-278.
22. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am. 2010;39(1):1-7.
23. Shiwaku K, Nogi A, Anuurad E, et al. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the b3-adrenergic receptor gene. Int J Obes. 2003;27:1028-1036. (Pubitemid 37059607)
24. Hutchison KE, Allen DL, Filbey FM, et al. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 2007;64(9): 1078-1086. (Pubitemid 47360853)
25. Jenkins NT, McKenzie JA, Damcott CM, Witkowski S, Hagberg JM. Endurance exercise training effects on body fatness V02max, HDL-C subfractions, and glucose tolerance are influenced by PLIN hapolotype in older caucasions. J Appl Physiol. 2010;108(3):498-506.
26. Bryan A, Hutchison KE, Seals DR, Allen DL. A transdisciplinary model integrating genetic, physiological and psychological correlates of voluntary exercise. Health Psychol. 2007;26(1):30-39. (Pubitemid 46072022)
27. Sonestedt E, Roos C, Gullberg B, Ericson U, Wirfalt E, Orho-Melander M. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr. 2009;90(5):1418-1425.
28. Arkadianos I, Valdes AM, Marinos E, Florou A, Gill RD, Grimaldi KA. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J. 2007;6:29.
29. Cho SW, Kang JY, Park YK, Paek YM, Choi TI. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype. Nutr Res. 2009;29(8): 542-550.
30. Rethorst CD, Landers DM, Nagoshi CT, Ross JTD. Efficacy of exercise in reducing depressive symptoms across 5-HTTLPR genotypes. Med Sci Sports Exerc. 2010;42(11):2141-2147.
31. Matsuo T, Nakata Y, Katayama Y, et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring). 2009;17(10): 1924-1931.
32. McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med. 2009;11(8):582-587.
33. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med. 2011;346(6):524-534.
34. McBride CM, Koehly LM, Sanderson SC, Kaphingst KA. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health. 2010;31:89-103.
35. Stice E, Dagher A. Genetic variation in dopaminergic reward in humans. Forum Nutr. 2010;63:176-185.
36. Noble EE, Billington C, Kotz CM, Wang C. The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol. 2011;300(5):R1053-R1069.
37. Bryan AD, Nilsson R, Tompkins SA, Magnan RE, Marcus BH, Hutchison KE. The big picture of individual differences in physical activity behavior change: a transdisciplinary approach. Psychol Sport Exerc. 2011;12(1):20-26.
38. Dallery J, Raiff BR. Contingency management in the 21st century: technological innovations to promote smoking cessation. Subst Use Misuse. 2011;46 (1):10-22.
39. Johnson MW, BickelWK, Kirshenbaum AP. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotinecontaining cigarettes. Drug Alcohol Depend. 2004;74(3):253-264. (Pubitemid 38759780)
40. Filbey FM, Claus ED, Morgan M, Forester GR, Hutchison K. Dopaminergic genes modulate response inhibition in alcohol abusing adults. Addict Biol. 2011; Epub ahead of print.
41. Hutchison KE. Substance use disorders: realizing the promise of pharmacogenomics and personalized medicine. Annu Rev Clin Psychol. 2010;6:577-589.
42. Swan GE, Hudmon KS, Jack LM, et al. Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiol Biomarkers Prev. 2003;12(10): 994-1005. (Pubitemid 37310254)
43. Sailors MH, Jackson AS, McFarlin BK, et al. Exposing college students to exercise: the Training Interventions and Genetics of Exercise Response (TIGER) study. J Am Coll Health. 2010;59(1): 13-20.
44. Emmons KM, Viswanath K, Colditz GA. The role of transdisciplinary collaboration in translating and disseminating health research: lessons learned and exemplars of success. Am J Prev Med. 2008;35(suppl 2):S204-S210. (Pubitemid 351932072)
45. Oliver JM, McGuire AL. Exploring the ELSI universe: critical issues in the evolution of human genomic research. Genome Med. 2011;3(6):38.
46. Hebert JR, Brandt HM, Armstead CA, Adams SA, Steck SE. Interdisciplinary, translational, and community-based participatory research: finding a common language to improve cancer research. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1213-1217.